Abstract:Abstract Trifolium resupinatum L., Fabaceae, aqueous methanol leaf extract was selected to mitigate some obesity-associated risk factors to validate the possibility of further developing herbal drugs. Chromatography and spectrophotometric techniques verified 14 phenolics, five of which were first isolated from the plant and identified as 6''- O -acetyl ononin, genistin, daidzin, sissotrin, and astragalin. Further phytochemical characterization was performed via liquid chromatography-electrospray ionization-mass spectrometry assisted by a spectral similarity molecular network. In total, 81 metabolites were tentatively annotated including 69 species-first dereplications. Two major isolates (formononetin and pseudobaptigenin) were selected along with the investigated extract for an in vitro pancreatic lipase inhibition assay. They showed notable effects with IC 50 values (μg/ml): 47.2 ± 1.1, 112.8 ± 1.23, and 471.32 ± 0.8, respectively, incomparable to orlistat (23.8 ± 0.64). Preliminary in vivo assay (25 mg/kg extract, daily, 8 weeks) displayed weight loss interest and promising advancement of serum triacylglycerides, total cholesterol, and glucose levels. Molecular docking studies confirmed the promising binding score of formononetin and pseudobaptigenin near the active sites and highlighted the affinity of other isolates to the lipase enzyme. Several isolates passed Lipinski’s law of the drug-likeness test, whereas SwissADME radar displayed that all constituents fall within the acceptable bioavailability zone. Therefore, the combination of flavonoids, especially isoflavones, could be regarded as drug-like agents for protection against obesity-induced metabolic complaints. Graphical Abstract

Synthesis and Biological Evaluation of Isoflavone Fatty Acid Esters with Potential Weight Loss and Hypolipidemic Activities

Synthesis and biological evaluation of new flavonoid fatty acid esters with anti-adipogenic and enhancing glucose consumption activities.

A New Synthetic Approach To Isoflavones

Synthesis and Biological Evaluation of Isoflavone Amide Derivatives with Antihyperlipidemic and Preadipocyte Antiproliferative Activities.

Anti-obesity Effect of an Isoflavone Fatty Acid Ester on Obese Mice Induced by High Fat Diet and Its Potential Mechanism

Synthesis and Biological Evaluation of Novel Bouchardatine Derivatives As Potential Adipogenesis/Lipogenesis Inhibitors for Antiobesity Treatment

Structure-guided Design and Synthesis of Isoflavone Analogs of GW4064 with Potent Lipid Accumulation Inhibitory Activities.

Synthesis and biological evaluation of novel urea- and guanidine-based derivatives for the treatment of obesity-related hepatic steatosis.

Lipid Accumulation Inhibitory Activities of Novel Isoxazole-Based Chenodeoxycholic Acids: Design, Synthesis and Preliminary Mechanism Study

Structural simplification and ester bond flipping lead to bis-benzodioxole derivatives as potential hypolipidemic and hepatoprotective agent

Synthesis and Estrogen-Like Activity of Resveratrol Analogues

Synthesis and biological evaluation of 3-methyl-5-phenylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione derivatives for the treatment of diet-induced obesity.

Synthesis and biological activity of novel barbituric and thiobarbituric acid derivatives against non-alcoholic fatty liver disease

Synthesis and Lipid-Lowering Evaluation of 3-Methyl-1h-purine-2,6-dione Derivatives As Potent and Orally Available Anti-Obesity Agents.

Isoflavone-Rich Extract of Trifolium resupinatum: Anti-obesity Attributes with In Silico Investigation of Its Constituents

Synthesis and Characterization of a Series of Genistein Derivatives As Selective Estrogen Receptor Modulators

Design, Synthesis and Biological Evaluation of Novel Bouchardatine Analogs As Potential Inhibitors of Adipogenesis/lipogenesis in 3T3-L1 Adipocytes

Soy Isoflavones Ameliorate Fatty Acid Metabolism Of Visceral Adipose Tissue By Increasing The Ampk Activity In Male Rats With Diet-Induced Obesity (Dio)

Synthesis and Lipid-Lowering Activity of Phenoxy Acetic Acid Derivatives

Creation of an Anti-Inflammatory, Leptin-Dependent Anti-Obesity Celastrol Mimic with Better Druggability

Design, synthesis and structure-activity relationship of novel 2-pyrimidinylindole derivatives as orally available anti-obesity agents